Skip to main content
4BASEBIO PLC logo

4BASEBIO PLC — Investor Relations & Filings

Listed
Ticker · 4BB ISIN · GB00BMCLYF79 LEI · 213800E2DX9EAIUNCB30 IL Manufacturing
Open in API
Filings indexed 104 across all filing types
Latest filing 2022-03-15 Regulatory Filings
Country GB United Kingdom
Listing IL 4BB · 7 venues

About 4BASEBIO PLC

https://www.4basebio.com/

4BASEBIO PLC is a biotechnology company specializing in the design and manufacturing of synthetic DNA for next-generation therapeutics and vaccines. The company provides high-purity, Good Manufacturing Practice (GMP) grade nucleic acid products, including its proprietary opDNA®, as a plasmid-free alternative to traditional methods. Its technology is engineered to accelerate development timelines, enhance safety, and improve manufacturing scalability for applications in genetic medicine, including mRNA vaccines, viral vector-based gene therapies, and gene editing. 4basebio's solutions aim to eliminate production bottlenecks and de-risk manufacturing for partners in the pharmaceutical and biotechnology sectors.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1910 characters) and contains the header 'RNS Number : 8626E'. It announces a 'Price Monitoring Extension' for a security, which is a specific operational update related to trading on the London Stock Exchange. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the Financial Conduct Authority (FCA). This type of brief, operational regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2022-03-15 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short operational announcement related to trading mechanics, not a comprehensive financial report or a standard corporate action like a dividend or management change. Given its nature as a brief, regulatory-mandated operational update distributed via the RNS system, and lacking a more specific category (like DIV, DIRS, or ER), the most appropriate classification is the general regulatory filing category.
2022-03-15 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1910 characters) and contains the header 'RNS Number : 8101E'. It announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange. It explicitly states that 'This information is provided by RNS, the news service of the London Stock Exchange' and is approved by the FCA as a Primary Information Provider. This structure—a brief, specific operational announcement distributed via the RNS system—fits best under the general Regulatory Filings category, as it is not a core financial report (like 10-K, IR, ER) nor a specific announcement like a dividend (DIV) or director dealing (DIRS). It is a miscellaneous regulatory notice.
2022-03-15 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1927 characters) and contains the header 'RNS Number : 0093E' and mentions 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement. This type of short, regulatory/exchange-related notice that doesn't fit a specific financial reporting category (like 10-K, ER, or IR) is best classified as a general Regulatory Filing (RNS), as it is distributed via the RNS system.
2022-03-08 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1910 characters) and contains the header 'RNS Number : 0089E'. It announces a 'Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the appropriate fallback is Regulatory Filings (RNS).
2022-03-08 English
4basebio Plc - DNA manufacturing update
Regulatory Filings Classification · 95% confidence The document is a press release dated February 15, 2022, providing an update on the company's DNA manufacturing progress, facility completion, hiring, and securing the first commercial order for research-grade DNA. It is not a formal regulatory filing like a 10-K or IR, nor is it a transcript (CT) or a specific financial report (ER, IR). It is an announcement providing operational and trading highlights. Since it details business progress and operational milestones, it fits best under the general category of a significant corporate announcement that doesn't map to a more specific financial or governance filing. Given the options, 'Regulatory Filings' (RNS) serves as the best general category for non-standard, material corporate updates released via PR Newswire, especially when the content is an operational update rather than a specific financial result release (ER) or a formal statutory report.
2022-02-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.